Related Experiment Video
Updated: Jun 8, 2026
09:56
Preparation and Characterization of Lipophilic Doxorubicin Pro-drug Micelles
Published on: August 2, 2016
Preparation and characterization of solid lipid nanoparticles containing cyclosporine by the emulsification-diffusion
Zaida Urbán-Morlán1, Adriana Ganem-Rondero, Luz María Melgoza-Contreras
1División de Estudios de Posgrado (Tecnología Farmacéutica), Facultad de Estudios Superiores Cuautitlán-Universidad Nacional Autónoma de México, Estado de México, México.
International Journal of Nanomedicine
|September 22, 2010
Summary
Solid lipid nanoparticles (SLNs) were prepared using Gelucire® for improved cyclosporine (CyA) delivery. Stable SLNs with high drug entrapment and rapid release were achieved, demonstrating potential for enhanced bioavailability.
Area of Science:
- Pharmaceutical Nanotechnology
- Drug Delivery Systems
- Materials Science
Background:
- Solid lipid nanoparticles (SLNs) are advanced carriers for therapeutic agents, enhancing absorption and bioavailability.
- Cyclosporine (CyA) is a vital immunosuppressant drug with challenges in absorption and bioavailability.
- Lipidic materials like Compritol® and Gelucire® are explored for SLN formulation.
Purpose of the Study:
- To prepare and characterize cyclosporine-loaded solid lipid nanoparticles (SLNs) using the emulsification-diffusion method.
- To evaluate the physicochemical stability of SLNs formulated with different lipidic carriers.
- To assess the impact of drug loading on SLN properties and in vitro release.
Main Methods:
- Preparation of SLNs containing cyclosporine (CyA) via emulsification-diffusion.
- Characterization of SLNs using particle size analysis, Z-potential, DSC, and SEM.
- Evaluation of entrapment efficiency and in vitro drug release profiles.
Main Results:
- Gelucire® yielded stable SLNs, whereas Compritol® resulted in unstable systems.
- High CyA loading (≥60 mg) in Gelucire® SLNs led to increased particle size over time.
- High entrapment efficiency (>92%) and rapid CyA release (99.60% in 45 min) were observed.
Conclusions:
- Gelucire® is a suitable lipid carrier for stable cyclosporine-loaded SLNs.
- SLN formulation can significantly enhance the delivery characteristics of cyclosporine.
- Further investigation is needed to elucidate the drug-lipid interaction mechanism affecting SLN stability.
